{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:17:42Z","timestamp":1762917462731,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.revmed.2013.04.014","type":"journal-article","created":{"date-parts":[[2013,6,3]],"date-time":"2013-06-03T18:17:10Z","timestamp":1370283430000},"page":"222-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Les glom\u00e9rulopathies associ\u00e9es aux n\u00e9oplasies my\u00e9loprolif\u00e9ratives"],"prefix":"10.1016","volume":"35","author":[{"given":"A.","family":"Bardy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tiple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rabant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-L.","family":"K\u00e9m\u00e9ny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"El Karoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hermet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Guettrot-Imbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Deteix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-O.","family":"Bay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Auma\u00eetre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2013.04.014_bib0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.revmed.2013.02.020","article-title":"Prise en charge diagnostique et th\u00e9rapeutique d\u2019un patient porteur d\u2019une thrombocytose","author":"Cheminant","year":"2013","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2013.04.014_bib0010","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2\u00a0in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2013.04.014_bib0015","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1158\/1078-0432.CCR-10-1613","article-title":"Molecular pathways: BCR-ABL","volume":"18","author":"Cilloni","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.revmed.2013.04.014_bib0020","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.leukres.2010.07.031","article-title":"Myeloid blastic transformation of myeloproliferative neoplasm \u2013 a review of 112\u00a0cases","volume":"35","author":"Noor","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.revmed.2013.04.014_bib0025","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1200\/JCO.2011.34.7542","article-title":"Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms","volume":"29","author":"Bj\u00f6rkholm","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.revmed.2013.04.014_bib0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","article-title":"Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia","volume":"128","author":"Elliott","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2013.04.014_bib0035","first-page":"13","article-title":"Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia","volume":"88","author":"Passamonti","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2013.04.014_bib0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000182807","article-title":"Essential thrombocytosis with acute renal failure due to bilateral thrombosis of the renal arteries and veins","volume":"32","author":"Bello Nicolau","year":"1982","journal-title":"Nephron"},{"key":"10.1016\/j.revmed.2013.04.014_bib0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.leukres.2009.07.009","article-title":"Renal failure associated with tyrosine kinase inhibitors \u2013 case report and review of the literature","volume":"34","author":"Gafter-Gvili","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.revmed.2013.04.014_bib0050","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2169\/internalmedicine.48.2747","article-title":"Acute kidney injury presenting a feature of leukemic infiltration during therapy for chronic myelogenous leukemia","volume":"49","author":"Yuzawa","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.revmed.2013.04.014_bib0055","first-page":"256","article-title":"Idiopathic myelofibrosis with extramedullary hematopoiesis in the kidney","volume":"52","author":"Schnuelle","year":"1999","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.revmed.2013.04.014_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.revmed.2012.12.013","article-title":"Glom\u00e9rulopathies associ\u00e9es aux syndromes my\u00e9loprolif\u00e9ratifs","author":"Paule","year":"2013","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2013.04.014_bib0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.leu.2404955","article-title":"Classification and diagnosis of myeloproliferative neoplasms: the 2008\u00a0World Health Organization criteria and point-of-care diagnostic algorithms","volume":"22","author":"Tefferi","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2013.04.014_bib0070","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.revmed.2013.04.014_bib0075","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ki.2011.147","article-title":"Myeloproliferative neoplasms cause glomerulopathy","volume":"80","author":"Said","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.revmed.2013.04.014_bib0080","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0272-6386(99)70047-8","article-title":"Focal segmental glomerulosclerosis and mesangial sclerosis associated with myeloproliferative disorders","volume":"34","author":"Au","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.revmed.2013.04.014_bib0085","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archinte.1974.00320150116015","article-title":"Erythrocytosis associated with chronic renal disease","volume":"133","author":"Basu","year":"1974","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2013.04.014_bib0090","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1001\/archinte.1977.03630200070019","article-title":"Erythrocytosis associated with the nephrotic syndrome","volume":"137","author":"Sonneborn","year":"1977","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2013.04.014_bib0095","first-page":"738","article-title":"Membranoproliferative glomerulonephritis secondary to chronic myeloid leukemia","volume":"21","author":"Subramanian","year":"2010","journal-title":"Saudi J Kidney Transpl"},{"key":"10.1016\/j.revmed.2013.04.014_bib0100","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/ndt\/15.10.1710-a","article-title":"Focal sclerosis with tip lesions secondary to polycythemia vera","volume":"15","author":"Kosch","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.revmed.2013.04.014_bib0105","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000188499","article-title":"Focal segmental glomerulosclerosis in a patient with polycythemia rubra vera","volume":"69","author":"Sharma","year":"1995","journal-title":"Nephron"},{"key":"10.1016\/j.revmed.2013.04.014_bib0110","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/08860220903573286","article-title":"Focal segmental glomerulosclerosis associated with idiopathic myelofibrosis","volume":"32","author":"Kaygusuz","year":"2010","journal-title":"Ren Fail"},{"key":"10.1016\/j.revmed.2013.04.014_bib0115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s10157-005-0391-6","article-title":"Focal segmental glomerulosclerosis associated with essential thrombocythemia","volume":"10","author":"Haraguchi","year":"2006","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.revmed.2013.04.014_bib0120","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/10428190290012245","article-title":"Nephrotic syndrome associated with agnogenic myeloid metaplasia","volume":"43","author":"Pamuk","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.revmed.2013.04.014_bib0125","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archinte.1983.00350010180036","article-title":"Chronic myelogenous leukemia with nephrotic syndrome","volume":"143","author":"Sudholt","year":"1983","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2013.04.014_bib0130","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0002-9343(86)90433-X","article-title":"Chronic myelogenous leukemia and glomerulonephritis: report of a new case","volume":"81","author":"Gago","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2013.04.014_bib0135","first-page":"169","article-title":"Idiopathic myelofibrosis associated with renal extramedullary hematopoiesis and nephrotic syndrome: case report","volume":"23","author":"Liu","year":"2000","journal-title":"Chang Gung Med J"},{"key":"10.1016\/j.revmed.2013.04.014_bib0140","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5414\/CNP68412","article-title":"Focal segmental glomerulosclerosis associated with polycythemia vera: report of a case and review of the literature","volume":"68","author":"Okuyama","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.revmed.2013.04.014_bib0145","first-page":"828","article-title":"Focal segmental glomerulosclerosis in a patient with polycythemia vera","volume":"47","author":"Iyoda","year":"2005","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"10.1016\/j.revmed.2013.04.014_bib0150","first-page":"656","article-title":"A case of essential thrombocytosis developing nephrotic syndrome and severe endothelial damage","volume":"19","author":"Saigusa","year":"2006","journal-title":"J Nephrol"},{"key":"10.1016\/j.revmed.2013.04.014_bib0155","first-page":"192","article-title":"Focal glomerulosclerosis and erythrocytosis","volume":"155","author":"Myers","year":"1979","journal-title":"Johns Hopkins Med J"},{"key":"10.1016\/j.revmed.2013.04.014_bib0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000168720","article-title":"Nephrotic syndrome associated with agnogenic myeloid metaplasia","volume":"14","author":"Perazella","year":"1994","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.revmed.2013.04.014_bib0165","doi-asserted-by":"crossref","first-page":"176","DOI":"10.5414\/CNP67176","article-title":"Chronic myeloid leukemia-associated membranoproliferative glomerulonephritis that responded to imatinib mesylate therapy","volume":"67","author":"Dwyers","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.revmed.2013.04.014_bib0170","first-page":"691","article-title":"A case of chronic myelogenous leukemia complicated with nephrotic syndrome","volume":"30","author":"Yoshizaki","year":"1989","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.revmed.2013.04.014_bib0175","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000068492","article-title":"A case of chronic myeloid leukemia complicated with minimal change nephrotic syndrome","volume":"109","author":"Talwar","year":"2003","journal-title":"Acta Haematol"},{"key":"10.1016\/j.revmed.2013.04.014_bib0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.nephro.2012.10.003","article-title":"Toxicit\u00e9 r\u00e9nale des antiangiog\u00e9niques","author":"Vigneau","year":"2013","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.revmed.2013.04.014_bib0185","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ndt\/gfs414","article-title":"Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in experimental anti-glomerular basement membrane nephritis","volume":"28","author":"Iyoda","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.revmed.2013.04.014_bib0190","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrneph.2010.171","article-title":"Pathogenesis diagnosis and management of paraneoplastic glomerulonephritis","volume":"7","author":"Lien","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.revmed.2013.04.014_bib0195","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2141.1991.tb07952.x","article-title":"Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia","volume":"77","author":"Martyr\u00e9","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2013.04.014_bib0200","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cyto.2010.07.427","article-title":"Evaluation of the bioactive and total transforming growth factor \u03b21\u00a0levels in primary myelofibrosis","volume":"53","author":"Campanelli","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.revmed.2013.04.014_bib0205","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.exphem.2006.07.004","article-title":"Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia","volume":"34","author":"Wang","year":"2006","journal-title":"Exp Hematol"},{"key":"10.1016\/j.revmed.2013.04.014_bib0210","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1681\/ASN.2007050532","article-title":"A new look at platelet-derived growth factor in renal disease","volume":"19","author":"Floege","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.revmed.2013.04.014_bib0215","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1523-1755.2005.00574.x","article-title":"The cyclin-dependent kinase inhibitor p21\u00a0is required for TGF-b1\u2013induced podocyte apoptosis","volume":"68","author":"Wada","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.revmed.2013.04.014_bib0220","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/ki.2008.487","article-title":"Inhibition of JAK2\u00a0protects renal endothelial and epithelial cells from oxidative stress and cyclosporin A toxicity","volume":"75","author":"Neria","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.revmed.2013.04.014_bib0225","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1056\/NEJMra1106556","article-title":"Focal segmental glomerulosclerosis","volume":"365","author":"D\u2019Agati","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2013.04.014_bib0230","doi-asserted-by":"crossref","first-page":"c79","DOI":"10.1159\/000335142","article-title":"Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature","volume":"120","author":"Kisner","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.revmed.2013.04.014_bib0235","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ki.2011.33","article-title":"A phase 1, single-dose study of fresolimumab, an anti-TGF-b antibody, in treatment-resistant primary focal segmental glomerulosclerosis","volume":"79","author":"Trachtman","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.revmed.2013.04.014_bib0240","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2141.2012.09108.x","article-title":"Janus kinase Inhibition and its effect upon the therapeutic landscape for myelofibrosis: from palliation to cure?","volume":"157","author":"Harrison","year":"2012","journal-title":"Br J Haematol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866313005110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866313005110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:32:35Z","timestamp":1759336355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866313005110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0248866313005110"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2013.04.014","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les glom\u00e9rulopathies associ\u00e9es aux n\u00e9oplasies my\u00e9loprolif\u00e9ratives","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2013.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}